N-acetylsphingosine

N-acetylsphingosine is a lipid of Sphingolipids (SP) class. N-acetylsphingosine is associated with abnormalities such as Morphologically altered structure, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and Gigantism. The involved functions are known as inhibitors, anti-apoptosis, Apoptosis, Dephosphorylation and immunoreactivity. N-acetylsphingosine often locates in Plasma membrane, Mitochondria, Pore, Membrane and Cytoplasmic matrix. The associated genes with N-acetylsphingosine are EGR3 gene, CFB gene, FATE1 gene, P4HTM gene and PFDN4 gene. The related lipids are Sphingolipids, Cardiolipins, Glycerophospholipids, dihydroceramide and Phosphatidic Acid.

Cross Reference

Introduction

To understand associated biological information of N-acetylsphingosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with N-acetylsphingosine?

N-acetylsphingosine is suspected in Morphologically altered structure, protrusion, DERMATITIS HERPETIFORMIS, FAMILIAL, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with N-acetylsphingosine

MeSH term MeSH ID Detail
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Helicobacter Infections D016481 21 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Retinoblastoma D012175 12 associated lipids
Parkinson Disease D010300 53 associated lipids
Neuronal Ceroid-Lipofuscinoses D009472 5 associated lipids
Nerve Degeneration D009410 53 associated lipids
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Lung Neoplasms D008175 171 associated lipids
Leukemia D007938 74 associated lipids
Insulin Resistance D007333 99 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Glioma D005910 112 associated lipids
Fever D005334 35 associated lipids
Eye Abnormalities D005124 7 associated lipids
Per page 10 20 50 | Total 26

PubChem Associated disorders and diseases

What pathways are associated with N-acetylsphingosine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with N-acetylsphingosine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with N-acetylsphingosine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with N-acetylsphingosine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with N-acetylsphingosine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with N-acetylsphingosine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with N-acetylsphingosine

Download all related citations
Per page 10 20 50 100 | Total 506
Authors Title Published Journal PubMed Link
Cotteret S et al. p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. 2003 Mol. Cell. Biol. pmid:12897128
Summers SA et al. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. 1998 Mol. Cell. Biol. pmid:9710629
Kazutaka S et al. Regulation of Sertoli cell activin A and inhibin B by tumour necrosis factor α and interleukin 1α: interaction with follicle-stimulating hormone/adenosine 3',5'-cyclic phosphate signalling. 2011 Mol. Cell. Endocrinol. pmid:21256182
Stoica BA et al. Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. 2003 Mol. Cell. Neurosci. pmid:12691738
Salinas M et al. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. 2000 Mol. Cell. Neurosci. pmid:10673324
Kim SH et al. Induction of apoptosis in chicken oviduct cells by C2-ceramide. 2005 Mol. Cells pmid:15879700
Puranam KL et al. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. 1999 Mol. Genet. Metab. pmid:10191118
Kondo T et al. Vesnarinone causes oxidative damage by inhibiting catalase function through ceramide action in myeloid cell apoptosis. 2002 Mol. Pharmacol. pmid:11854443
Ramos B et al. Inhibition of CTP:phosphocholine cytidylyltransferase by C(2)-ceramide and its relationship to apoptosis. 2002 Mol. Pharmacol. pmid:12391269
Cho YH et al. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages. 2003 Mol. Pharmacol. pmid:12606757
Ramos B et al. Prevalence of necrosis in C2-ceramide-induced cytotoxicity in NB16 neuroblastoma cells. 2003 Mol. Pharmacol. pmid:12869656
Park IN et al. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system. 2004 Mol. Pharmacol. pmid:15155840
Chen CC et al. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. 2001 Mol. Pharmacol. pmid:11179444
de Castro e Paula LA and Hansen PJ Ceramide inhibits development and cytokinesis and induces apoptosis in preimplantation bovine embryos. 2008 Mol. Reprod. Dev. pmid:18157869
Samadi A Ceramide-induced cell death in lens epithelial cells. 2007 Mol. Vis. pmid:17893663
Hama-Inaba H et al. Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation. 1998 Mutat. Res. pmid:9726009
Tan KB et al. Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia. 2014 Nanomedicine (Lond) pmid:24294981
Galve-Roperh I et al. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. 2000 Nat. Med. pmid:10700234
Verheij M et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. 1996 Nature pmid:8598911
Cuvillier O et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. 1996 Nature pmid:8657285